COMBINED USE OF A CHEMOTHERAPEUTIC AGENT AND A CYCLIC DINUCLEOTIDE FOR CANCER TREATMENT

摘要

A kit of parts comprising a) gemcitabine or a pharmaceutically acceptable salt thereof and b) a cyclic dinucleotide or pharmaceutically acceptable salt thereof, wherein said cyclic dinucleotide or pharmaceutically acceptable salt thereof is an agonist of the receptor known as "stimulator of interferon genes" (STING), for use in the treatment of solid pancreatic cancer.